Kestra Medical Technologies
(NASDAQ) KMTS
Kestra Medical Technologies Financials at a Glance
Market Cap
$1.21B
Revenue (TTM)
$83.72M
Net Income (TTM)
-$144.83M
EPS (TTM)
-$2.81
P/E Ratio
-7.36
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$22.08
Volume
311,421.117
Open
$20.78
Price
$22.08
Volume
311,421.117
Open
$20.78
Previous Close
$22.08
Daily Range
$20.65 - $22.69
52-Week Range
$13.25 - $30.00
Estimated Earnings Date
Jul 21, 2026
Dividend
$0.00
Beta (Volatility)
1.48 (Average)
Price
$22.08
Volume
311,421.117
Open
$20.78
Previous Close
$22.08
Daily Range
$20.65 - $22.69
52-Week Range
$13.25 - $30.00
Estimated Earnings Date
Jul 21, 2026
KMTS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kestra Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
330
CEO
Brian Webster, MBA
Website
www.kestramedical.com/aboutHeadquarters
Kirkland, WA 98033, US
KMTS Financials
Key Financial Metrics (TTM)
Gross Margin
48.75%
Operating Margin
-171.53%
Net Income Margin
-172.99%
Return on Equity
-68.83%
Return on Capital
-42.60%
Return on Assets
-38.18%
Earnings Yield
-13.59%
Dividend Yield
0.00%
Payout Ratio
-0.02%
Stock Overview
Market Cap
$1.21B
Shares Outstanding
58.37M
Volume
311.42K
Avg. Volume
292.95K
Financials (TTM)
Gross Profit
$40.81M
Operating Income
-$143.61M
EBITDA
-$128.00M
Operating Cash Flow
-$86.68M
Capital Expenditure
-$33.27M
Free Cash Flow
-$119.95M
Cash & ST Invst.
$291.32M
Total Debt
$4.29M
Kestra Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.55M
+62.7%
Gross Profit
$12.91M
+97.1%
Gross Margin
52.57%
N/A
Market Cap
$1.21B
N/A
Market Cap/Employee
$4.03M
N/A
Employees
300
N/A
Net Income
-$34.17M
-58.8%
EBITDA
-$30.26M
-67.5%
Quarterly Fundamentals
Total Cash
$291.32M
+436.0%
Total Debt
$4.29M
-90.8%
Accounts Receivable
$12.71M
+60.3%
Inventory
$6.83M
+13.8%
Long Term Debt
$46.54M
-0.2%
Short Term Debt
$10.00K
N/A
Return on Assets
-38.18%
N/A
Return on Invested Capital
-42.69%
N/A
Free Cash Flow
-$28.16M
-25.5%
Operating Cash Flow
-$18.37M
+0.1%